Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1368 ARTÍCULOS , VIENDO DEL 421 AL 435

Phosphodiesterase 5 inhibitors as novel agents for the treatment of Alzheimer's disease

Liu L, Xu H, Ding S, Wang D, Song G, Huang X.

Brain Res Bull. 2019 Nov;153:223-231. doi: 10.1016/j.brainresbull.2019.09.001. Epub 2019 Sep 4.

The extracellular matrix of the blood-brain barrier: structural and functional roles in health, aging, and Alzheimer's disease

Reed MJ, Damodarasamy M, Banks WA.

Tissue Barriers. 2019;7(4):1651157. doi: 10.1080/21688370.2019.1651157. Epub 2019 Sep 11.

Recent tau-targeted clinical strategies for the treatment of Alzheimer's disease

Lee HE, Lim D, Lee JY, Lim SM, Pae AN.

Future Med Chem. 2019 Aug;11(15):1845-1848. doi: 10.4155/fmc-2019-0151.

From Return of Information to Return of Value: Ethical Considerations when Sharing Individual-Level Research Data

Nebeker C, Leow AD, Moore RC.

J Alzheimers Dis. 2019;71(4):1081-1088. doi: 10.3233/JAD-190589.

Overview of Transgenic Mouse Models for Alzheimer's Disease

Myers A, McGonigle P.

Curr Protoc Neurosci. 2019 Sep;89(1):e81. doi: 10.1002/cpns.81.

Historical Migration revealed through a Case of Autosomal Dominant Alzheimer's Disease

Poblete J, Dokuru D, Coppola G, Ortiz F, Medina LD, Vinters HV, Ringman JM.

P R Health Sci J. 2019 Sep;38(3):144-147.

Alzheimer's disease pathogenesis: The role of disturbed sleep in attenuated brain plasticity and neurodegenerative processes

Havekes R, Heckman PRA, Wams EJ, Stasiukonyte N, Meerlo P, Eisel ULM.

Cell Signal. 2019 Dec;64:109420. doi: 10.1016/j.cellsig.2019.109420. Epub 2019 Sep 16.

Phosphodiesterase inhibitors say NO to Alzheimer's disease

Nabavi SM, Talarek S, Listos J, Nabavi SF, Devi KP, Roberto de Oliveira M, Tewari D, Argüelles S, Mehrzadi S, Hosseinzadeh A, D'onofrio G, Orhan IE, Sureda A, Xu S, Momtaz S, Farzaei MH.

Food Chem Toxicol. 2019 Dec;134:110822. doi: 10.1016/j.fct.2019.110822. Epub 2019 Sep 16.

Highly Significant Scaffolds to Design and Synthesis Cholinesterase Inhibitors as Anti-Alzheimer Agents

Pourshojaei Y, Eskandari K, Asadipour A.

Mini Rev Med Chem. 2019;19(19):1577-1598. doi: 10.2174/1389557519666190719143112.

Interferons: A molecular switch between damage and repair in ageing and Alzheimer's disease

Gorlé N, Vandenbroucke RE.

Mech Ageing Dev. 2019 Oct;183:111148. doi: 10.1016/j.mad.2019.111148. Epub 2019 Sep 18.

Nutritional Interventions for Persons With Early-Stage Dementia or Alzheimer's Disease: An Integrative Review

Testad I, Kajander M, Froiland CT, Corbett A, Gjestsen MT, Anderson JG.

Res Gerontol Nurs. 2019 Sep 1;12(5):259-268. doi: 10.3928/19404921-20190813-02.

The Link of the Prion Protein with Ca(2+) Metabolism and ROS Production, and the Possible Implication in Aβ Toxicity

De Mario A, Peggion C, Massimino ML, Norante RP, Zulian A, Bertoli A, Sorgato MC.

Int J Mol Sci. 2019 Sep 19;20(18):4640. doi: 10.3390/ijms20184640.

Alzheimer Disease: An Update on Pathobiology and Treatment Strategies

Long JM, Holtzman DM.

Cell. 2019 Oct 3;179(2):312-339. doi: 10.1016/j.cell.2019.09.001. Epub 2019 Sep 26.

Nutrients in the Prevention of Alzheimer's Disease

Cremonini AL, Caffa I, Cea M, Nencioni A, Odetti P, Monacelli F.

Oxid Med Cell Longev. 2019 Sep 4;2019:9874159. doi: 10.1155/2019/9874159. eCollection 2019.

Is Alzheimer's disease an inflammasomopathy?

Pereira CF, Santos AE, Moreira PI, Pereira AC, Sousa FJ, Cardoso SM, Cruz MT.

Ageing Res Rev. 2019 Dec;56:100966. doi: 10.1016/j.arr.2019.100966. Epub 2019 Sep 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias